Retinoid target gene activation during induced tumor cell differentiation: Human embryonal carcinoma as a model

Journal of Nutrition

Volumn 133, Issue 1, 2003, Pages

  Spinella, Michael J ^a   Kerley, Joanna S ^a   White, Kristina A ^a   Curtin, Joshua C ^a  

^a NONE

Author keywords

Chemoprevention; Differentiation; Embryonal carcinoma; Microarray; Retinoic acid

Indexed keywords

RETINOIC ACID RECEPTOR; RETINOID;

ANTINEOPLASTIC ACTIVITY; CANCER MODEL; CELL DIFFERENTIATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG RECEPTOR BINDING; EMBRYONAL CARCINOMA; GENE ACTIVATION; GENE TARGETING; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; PHENOTYPE; RECEPTOR UPREGULATION; TRANSCRIPTION REGULATION; TUMOR CELL;

EID: 0037226984     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/133.1.273s     Document Type: Conference Paper

References (36)

1. Sporn, M. B., Dunlop, N. M., Newton, D. L. & Smith, J. M. (1976) Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed. Proc. 35: 1332-1338.
2. Rifkind, R. A., Richon, V. M. & Marks, P. A. (1996) Induced differentiation, the cell cycle, and the treatment of cancer. Pharmacol. Ther. 69: 97-102.
3. Hong, W. K. & Itri, L.M. (1994) Retinoids and human cancer. In: The Retinoids: Biology, Chemistry and Medicine. (Sporn, M. B., Roberts A. B. & Goodman D, S., eds.), 2nd ed., pp. 597-630. Raven Press, New York, NY.
4. Nason-Burchenal, K. & Dmitrovsky, E. (1999) The retinoids: cancer therapy and prevention mechanisms. In: Retinoids: Handbook of Experimental Pharmacology (Nau, H. & Blaner, W. S., eds.), Vol. 139, pp. 301-322. Springer, Berlin.
5. Hong, W. K. & Sporn, M. B. (1997) Recent advances in chemoprevention of cancer. Science (Washington, D.C.) 278: 1073-1077.
6. Wolbach, S. B. & Howe, P. R. (1925) Tissue changes following deprivation of fat-soluble A vitamin. J. Exp. Med. 42: 753-777.
7. Moon, R. C., Mehta, R. G. & Rao, K. V. (1994) Retinoids and cancer in experimental animals. In: The Retinoids: Biology, Chemistry and Medicine. (Sporn, M. B., Roberts A. B. & Goodman D. S., eds.), 2nd ed., pp. 573-595. Raven Press, New York, NY.
8. Chambon, P. (1996) A decade of molecular biology of retinoic acid receptors. FASEB J. 10: 940-954.
9. Mangelsdorf, D. J., Umesono, K. & Evans, R. M. (1994) The retinoid receptors. In: The Retinoids: Biology, Chemistry and Medicine, (Sporn, M, B., Roberts A. B. & Goodman D. S., eds.), 2nd ed., pp. 319-349. Raven Press, New York, NY.
10. Chaganti, R. S. & Houldsworth, J. (2000) Genetics and biology of adult human male germ cell tumors. Cancer Res. 60: 1475-1482.
11. Schottenfeld, D., Warshauer, M. E., Sherlock, S., Zauber, A. G., Leder, M. & Payne, R. (1980) The epidemiology of testicular cancer in young adults. Am. J. Epidemiol. 112: 232-246.
12. Heidenreich, A., Srivastava, S., Moul, J. W. & Hofmann, R. (2000) Molecular genetic parameters in pathogenesis and prognosis of testicular germ cell tumors. Eur. Urol. 37: 121-135.
13. Andrews, P. W. (1998) Teratocarcinomas and human embryology: pluripotent human EC cell lines. APMIS 106: 158-168.
14. Pera, M. F., Roach, S. & Elliss, C. J. (1990) Comparative biology of mouse and human embryonal carcinoma. Cancer Surv. 9: 243-262.
15. Matin, A., Collin, G. B., Varnum, D. S. & Nadeau, J. H. (1998) Testicular teratocarcinogenesis in mice: a review. APMIS 106: 174-182.
16. Andrews, P. W. (1984) Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol. 103: 285-293.
17. Kurie, J. M., Buck, J., Eppinger, T. M., Moy, D. & Dmitrovsky, E. (1993) 9-cis and all-trans retinoic acid induce a similar phenotype in human teratocarcinoma cells. Differentiation 54: 123-129.
18. Spinella, M. J., Freemantle, S. J., Sekula, D., Chang, J. H., Christie, A. J. & Dmitrovsky, E. (1999) Retinoic acid promotes ubiquitination and proteolysis of cyclin D1 during induced tumor cell differentiation. J. Biol. Chem. 274: 22013-22018.
19. Przyborski, S. A., Morton, I. E., Wood, A. & Andrews, P. W. (2000) Developmental regulation of neurogenesis in the pluripotent human embryonal carcinoma cell line NTERA-2. Eur. J. Neurosci. 12: 3521-3528.
20. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S. & Jones, J. M. (1998) Embryonic stem cell lines derived from human blastocysts, Science (Washington, D.C.) 282: 1145-1147.
21. Pera, M. F., Reubinoff, B. & Trounson, A. (2000) Human embryonic stem cells, J. Cell. Sci. 113: 5-10.
22. Moasser, M. M., Khoo, K. S., Maerz, W. J., Zelenetz, A. & Dmitrovsky, E. (1996) Derivation and characterization of retinoid-resistant human embryonal carcinoma cells. Differentiation 60: 251-257.
23. Spinella, M. J., Kitareewan, S., Mellado, B., Sekula, D., Khoo, K. S. & Dmitrovsky, E. (1998) Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells. Oncogene 16: 3471-3480.
24. Moasser, M. M., DeBlasio, A. & Dmitrovsky, E. (1994) Overexpression of retinoic acid receptor-γ in human teratocarcinomas. Oncogene 9: 833-840.
25. Curtin, J. C., Dragnev, K. H., Sekula, D., Christie, A. J., Dmitrovsky, E. & Spinella, M. J. (2001) Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation function. Oncogene 20: 2559-2569.
26. Shin, D. M., Xu, X. C., Lippman, S. M., Lee, J. J., Lee, J. S., Batsakis, J. G., Ro, J. Y., Martin, J. W., Hittelman, W. N., Lotan, R. & Hong, W. K. (1997) Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention. Clin. Cancer Res. 3: 875-880.
27. Shin, D. M., Mao, L., Papadimitrakopoulou, V. M., Clayman, G., El-Naggar, A., Shin, H. J., Lee, J. J., Lee, J. S., Gillenwater, A., Myers, J., Lippman, S. M., Hittelman, W. N. & Hong, W. K. (2000) Biochemoprevention therapy for patients with premalignant lesions of the head and neck and p53 gene expression. J. Natl. Cancer. Inst. 92: 69-73.
28. Freemantle, S. J., Kerley, J. S., Olsen, S. L., Gross, R. H. & Spinella, M. J. (2002) Developmentally-related candidate retinoic acid target genes regulated early during neuronal differentiation of human embryonal carcinoma. Oncogene 21:2880-2889.
29. Dmitrovsky, E., Bosi, G. J. & Chaganti, R. S. (1990) Clinical and genetic aspects of human germ cell cancer. Cancer Surv, 9: 369-386.
30. Peng, H. Q., Hogg, D., Malkin, D., Bailey, D., Gallie, B. L., Bulbul, M., Jewett, M., Buchanan, J. & Gross, P. E. (1993) Mutations of the p53 gene do not occur in testis cancer. Cancer Res. 53; 3574-3578.
31. Heimdal, K., Lothe, R. A., Lystad; S., Holm, R., Fossa, S. D. & Borresen, A. L. (1993) No germline TP53 mutations detected in familial and bilateral testicular cancers. Genes Chromosom. Cancer 6: 92-97.
32. Lutzker, S. G. & Levine, A. J. (1996) A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation. Nat. Med. 2: 804-810.
33. Calvo, R. & Drabkin, H. A. (2000) Embryonic genes is cancer. Ann. Oncol. 11: 207-218.
34. Subramaniam, N., Treuter, E., & Okret, S. (1999) Receptor interacting protein RIP140 inhibits both positive and negative gene regulation by glucocorticoids. J. Biol. Chem. 274: 18121-18127.
35. Wei, L, N., Hu, X., Chandra, D., Seto, E., & Farooqui, M. (2000) Receptor-interacting protein 140 directly recruits histone deacetylases for gene silencing. J. Biol. Chem. 275: 40782-40787.
36. Kerley, J. S., Olsen, S. L., Freemantle, S. J. & Spinella, M. J. (2001) Transcriptional activation of the nuclear receptor corepressor RIP140 by retinoic acid: a potential negative-feedback regulatory mechanism. Biochem. Biophys. Res. Commun. 285: 969-975.